Regen BioPharma, Inc. Announces ucVax: Universal Donor Cancer Cellular Immunotherapy

SAN DIEGO, May 19, 2016 /PRNewswire/ —

Regen BioPharma, Inc. (OTCBB: RGBP), (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today initiation of a preclinical development program aimed at creating the first cord blood based cancer immunotherapeutic product leveraging its NR2F6…
Source: PRNewsWire-USA

Regen BioPharma, Inc. Announces ucVax: Universal Donor Cancer Cellular Immunotherapy